2019
Patients' reasons for weight loss and their relations to clinical weight loss outcomes in a comprehensive lifestyle intervention
Boepple L, Cero I, Marek RJ, Coulon S, Lydecker JA, Brown JD, Malcolm R, O'Neil PM. Patients' reasons for weight loss and their relations to clinical weight loss outcomes in a comprehensive lifestyle intervention. Obesity Science & Practice 2019, 5: 548-554. PMID: 31890245, PMCID: PMC6934423, DOI: 10.1002/osp4.372.Peer-Reviewed Original ResearchWeight loss outcomesBody mass indexWeight change outcomesLoss outcomesWeight lossWhite patientsBlack patientsHigher Body Mass IndexComprehensive lifestyle interventionWeight loss trajectoriesCertain patient groupsWeight loss treatmentWeight loss programLifestyle interventionPatient characteristicsMale patientsPatients' reasonsFemale patientsMass indexPercent weight lossLoss programPatient groupWorse outcomesDoctor's recommendationLoss treatment
2016
Perioperative Safety of Warfarin Therapy and Reversal.
Maslin B, Springer E, Zhu R, Kodumudi V, Vadivelu N. Perioperative Safety of Warfarin Therapy and Reversal. Current Drug Safety 2016, 11: 149-55. PMID: 26674352, DOI: 10.2174/1574886311666151217121553.Peer-Reviewed Original ResearchConceptsWarfarin therapyEmergent surgeryPatient groupMultidisciplinary consensus guidelinesRisk stratification algorithmCertain patient groupsVulnerable patient groupRegional anesthetic techniquesClinical decision pointsUnited States populationThromboembolic consequencesPerioperative periodPerioperative safetyBlood lossPerioperative careProcedural complicationsClinical outcomesPreoperative patientsAnesthetic techniqueRetrospective studyConsensus guidelinesPerioperative cliniciansClinical trialsCoordinated careClinical studies
2014
Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-Hour Exclusions and Association With Outcome
Cronin CA, Sheth KN, Zhao X, Messé SR, Olson DM, Hernandez AF, Bhatt DL, Schwamm LH, Smith EE. Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-Hour Exclusions and Association With Outcome. Stroke 2014, 45: 2745-2749. PMID: 25104846, DOI: 10.1161/strokeaha.114.005443.Peer-Reviewed Original ResearchConceptsAdditional exclusion criteriaExclusion criteriaDiabetes mellitusAmerican Heart Association/American Stroke Association guidelinesEuropean Cooperative Acute Stroke StudyAmerican Stroke Association guidelinesSymptomatic intracranial hemorrhageWorse hospital outcomesHealth Stroke ScalePercent of patientsHistory of strokeOral anticoagulant treatmentCertain patient groupsAcute Stroke StudyTreatment time windowHour windowECASS IIIGuidelines-StrokePrior strokeAnticoagulant treatmentHospital outcomesStroke ScaleIschemic strokeSymptom onsetIncreased risk
2003
Cost-Effectiveness of Risk Factors
Heidenreich P, Krumholz H. Cost-Effectiveness of Risk Factors. 2003, 259-272. DOI: 10.1007/978-1-4615-6484-3_13.Peer-Reviewed Original Research
2000
Cost-Effectiveness of Risk Factors
Krumholz H, Goldman L. Cost-Effectiveness of Risk Factors. 2000, 237-250. DOI: 10.1007/978-1-4757-9310-9_13.Peer-Reviewed Original Research
1997
Frailty and Hospitalization of Long‐Term Stay Nursing Home Residents
Fried T, Mor V. Frailty and Hospitalization of Long‐Term Stay Nursing Home Residents. Journal Of The American Geriatrics Society 1997, 45: 265-269. PMID: 9063269, DOI: 10.1111/j.1532-5415.1997.tb00938.x.Peer-Reviewed Original ResearchConceptsCongestive heart failurePrimary diagnosisNursing homesHeart failureRespiratory diseaseRecent functional declineNursing home patientsSevere functional impairmentCertain patient groupsNursing home stayNursing home residentsProprietary nursing homesLower ratesLogistic regression modelsCohort studyAcute careHome patientsHospitalization ratesPatient groupFeeding tubeDecubitus ulcersFunctional impairmentHome residentsFunctional declineHospitalization
1981
Multimodal treatment of primary breast carcinoma Analysis of accomplishments and problem areas
Weiss R, Henney J, DeVita V. Multimodal treatment of primary breast carcinoma Analysis of accomplishments and problem areas. The American Journal Of Medicine 1981, 70: 844-851. PMID: 7011024, DOI: 10.1016/0002-9343(81)90541-6.Peer-Reviewed Original ResearchConceptsAxillary nodesInvolved axillary nodesDisease-free survivalUse of chemotherapyBreast carcinoma patientsCertain patient groupsFuture clinical trialsPrimary breast carcinomaBetter therapeutic indexMurine tumor modelsCarcinoma patientsDrug regimensMultimodal treatmentPatient groupClinical trialsBreast carcinomaBreast cancerTherapeutic indexChemotherapy modePatientsSpecific subgroupsTumor modelMastectomyChemotherapyHuman subjects
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply